Drug assessment: responsibilities of the department
The main responsibility of the department is to assess the benefits and harms of drugs approved in Germany. For this purpose, it compares drugs with each other as well as with non-drug interventions. The aim of these comparisons is to establish which treatment alternative shows which advantages and disadvantages for patients.
In collaboration with external experts, the department prepares
- early benefit assessments (dossier assessments)
Dossiers submitted by the drug manufacturer to the G-BA form the basis of early benefit assessments. The results are published in the form of a dossier assessment. These early assessments are the consequence of the regulations set out in the Act on the Reform of the Market for Medicinal Products (AMNOG), which became effective in 2011. - benefit assessments (reports, rapid reports)
These benefit assessments are based on our own systematic search for published and unpublished studies. These results are published as a report or rapid report.
In these assessments the department applies methods and processes adapted to the respective objectives of a project.
Further responsibilities:
- further development of methods for assessing the benefits and harms of drugs.
- cooperation in international working groups (especially within the European Network EUNetHTA).
- in talks and publications, dissemination of IQWiG's methods and results as well as of other new scientific findings arising from the department's work.
Drug Assessment: Staff
Dr. rer. nat. Beate Wieseler
Professional profile
Degree in Biology (Universities of Bonn and Freiburg). 1989 - 1994: Research Associate at the Universities of Bonn, Freiburg, and Munich (LMU). 1993 - 1995: Scientific journalist. 1996 - 2005: Clinical research at "gmi” (Organization for Applied Mathematics and Informatics) and Kendle International Inc.: planning, analysis, and reporting of clinical trials. Preparation of submission dossiers. Development and conduct of workshops on topics related to clinical research and drug development. 1997 - 2005 Head of the European Medical Writing Department, Kendle International Inc. April 2005 - September 2011: Deputy Head of IQWiG's Drug Assessment Department; Since October 2011: Head of IQWiG's Drug Assessment Department.
Dr. rer. nat. Daniela Preukschat
Professional profile
Studied biology and sports science in Cologne; 2008 - 2013 Research Associate at the University of Cologne, Institute of Genetics; 2014-2016: Scientific Advisor at the Medical Advisory Service of the German Social Health Insurance (MDS), Evidence-Based Medicine Division, Essen: Preparation and Assessment of HTA Reports, Advisor to the National Association of Statutory Health Insurance Funds ( GKV-Spitzenverband); since July 2016, Research Associate in the IQWiG Drug Assessment Department; since May 2021, Head of the Chronic Diseases Division.
Katrin Nink
Professional profile
Degree in pharmacy, University of Bonn; postgraduate studies in health sciences in Bielefeld (MPH); 1998 - 2001: researcher at the consumer centre North Rhine-Westfalia (NRW) in health consumer protection, 2001 to 2012: Scientific Institute of the AOK (WIdO), last position: Head of the research area "Drug Index of the Statutory Health Insurance (GKV)"; 2012-2020: research associate at IQWiG in the Drug Assessment Department; 2020-2023: Head of the Division of Haemato-Oncology and Infectious Diseases; since 2023: Head of the Division of Oncology (solid tumours) and Routine Practice Data Collection
Dr. med. vet. Volker Vervölgyi, MSc (Epidemiology)
Professional profile
Degree in veterinary medicine, Justus Liebig University Giessen; 2003-2006: research associate at the Institute of Physiology I, Rheinische Friedrich-Wilhelms University Bonn; doctorate (Dr. med. vet.); 2005-2009: Degree in epidemiology, Johannes Gutenberg University Mainz; 2006-2014: research associate at IQWiG in the Drug Assessment Department; 2014-2019 Deputy Head of Department; 2019-2023: Head of the Oncology Division (solid tumours); since 2023: Head of the Division of Oncology (solid tumours) and Routine Practice Data Collection
Dr. med. Philip Kranz
Professional profile
Degree in medicine, University of Essen; 2017-2018: researcher at the University Hospital Essen, Institute of Physiology - completion of a doctorate in medicine (Dr. med.); 2019-2020: assistant physician at the Alfried Krupp Hospital in Essen, Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy; since March 2020: researcher at IQWiG in the Drug Assessment Department; since October 2023: Head of the Division of Haemato-Oncology and Infectious Diseases.
Dr. med. Regina Skavron
Professional profile
Degree in medicine and doctorate at the University of Cologne; 2005-2006: Fellowship at the WHO Regional Office for Europe in Copenhagen; 2006-2007: M.Sc. in "Health Policy, Planning & Financing" at the London School of Hygiene & Tropical Medicine (LSHTM) and the London School of Economics & Political Science (LSE); 2007-2024: Scientific Advisor in the Pharmaceuticals Department of the Federal Joint Committee (G-BA), more recently Team Leader for non-oncology products assessed according to AMNOG (Act on the Reform of the Market for Medicinal Products); since April 2024: Division Head, Methodology and Coordination of European HTA of Drugs
Dr. Sascha Abbas
Dr. Selver Altin
Dr. rer. nat. Anna-Katharina Barnert
Erika Baumbach
Dr. rer. nat. Philip Böhler
Dr. med. Dr. rer. nat. Simon Bogner
Concetta Cannistraci
Dr. rer. nat. Annette Christoph
Dr. rer. nat. Ivona Djuric
Susanne Ebrahim
Sema Erden
Christina Frings
Lukas Gockel
Dr. rer. nat. Jana Göbel
Dr. rer. nat. Jonas Goretzko
Dr. rer.nat. Raphaela Gorris
Carolin Haubenreich
Dr. rer. nat. Michael Hort
Dr. rer. nat. Anne Hüning
Dr. Deborah Ingenhag-Reister
Dr. Kirsten Janke
Dr. Simone Johner
Dr. rer. nat. Lisa Junge
Jana Kalz-Müller
Christina Keksel
Michaela Florina Kerekes
Michael Köhler
Petra Kohlepp
Teresa Labahn
Yvonne Lammering
Dr. Ana Liberman
Annette Loh
Dr. rer. nat. Sebastian Meller
Dr. rer. nat. Ulrike Mikulić
Prateek Mishra
Dr. rer. nat. Bent Müller
Sabine Ostlender
Isabelle Paulußen
Anne-Kathrin Petri
Dr. rer. nat. Regine Potthast
Dr. Annette Pusch-Klein
Katharina Quitmann
Dr. rer. nat. Alina Reese
Dr. rer. nat. Anja Reinartz
Stefanie Reken
Veronika Schneck
Ulrike Seay
Dr. rer. nat. Claudia Selbach
Dr. rer. nat. Christian Siebel
Dr. phil. Barbara Julia Spix
Dr. rer. nat. Can Ünal
Elke Vervölgyi
Valerie Wandres
Caroline Wöhl
Dr. Katharina Wölke
Dr. rer. nat. Marina Woeste
Dr. Charlotte Zeitler